BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

748 related articles for article (PubMed ID: 10756044)

  • 1. Virus-specific cofactor requirement and chimeric hepatitis C virus/GB virus B nonstructural protein 3.
    Butkiewicz N; Yao N; Zhong W; Wright-Minogue J; Ingravallo P; Zhang R; Durkin J; Standring DN; Baroudy BM; Sangar DV; Lemon SM; Lau JY; Hong Z
    J Virol; 2000 May; 74(9):4291-301. PubMed ID: 10756044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nucleoside triphosphatase and RNA helicase activities associated with GB virus B nonstructural protein 3.
    Zhong W; Ingravallo P; Wright-Minogue J; Skelton A; Uss AS; Chase R; Yao N; Lau JY; Hong Z
    Virology; 1999 Sep; 261(2):216-26. PubMed ID: 10497107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Processing of GB virus B non-structural proteins in cultured cells requires both NS3 protease and NS4A cofactor.
    Sbardellati A; Scarselli E; Amati V; Falcinelli S; Kekulé AS; Traboni C
    J Gen Virol; 2000 Sep; 81(Pt 9):2183-2188. PubMed ID: 10950975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparative analysis of the substrate permissiveness of HCV and GBV-B NS3/4A proteases reveals genetic evidence for an interaction with NS4B protein during genome replication.
    Benureau Y; Warter L; Malcolm BA; Martin A
    Virology; 2010 Oct; 406(2):228-40. PubMed ID: 20701941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GB virus B and hepatitis C virus NS3 serine proteases share substrate specificity.
    Scarselli E; Urbani A; Sbardellati A; Tomei L; De Francesco R; Traboni C
    J Virol; 1997 Jul; 71(7):4985-9. PubMed ID: 9188562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular views of viral polyprotein processing revealed by the crystal structure of the hepatitis C virus bifunctional protease-helicase.
    Yao N; Reichert P; Taremi SS; Prosise WW; Weber PC
    Structure; 1999 Nov; 7(11):1353-63. PubMed ID: 10574797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NS3 serine protease of bovine viral diarrhea virus: characterization of active site residues, NS4A cofactor domain, and protease-cofactor interactions.
    Tautz N; Kaiser A; Thiel HJ
    Virology; 2000 Aug; 273(2):351-63. PubMed ID: 10915606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple enzymatic activities associated with recombinant NS3 protein of hepatitis C virus.
    Gallinari P; Brennan D; Nardi C; Brunetti M; Tomei L; Steinkühler C; De Francesco R
    J Virol; 1998 Aug; 72(8):6758-69. PubMed ID: 9658124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of hepatitis C virus NS3 protease and helicase activities through the interaction with NS4A.
    Gallinari P; Paolini C; Brennan D; Nardi C; Steinkühler C; De Francesco R
    Biochemistry; 1999 Apr; 38(17):5620-32. PubMed ID: 10220351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of the fused NS4A peptide-NS3 protease domain to study the importance of the helicase domain for protease inhibitor binding to hepatitis C virus NS3-NS4A.
    Thibeault D; Massariol MJ; Zhao S; Welchner E; Goudreau N; Gingras R; Llinàs-Brunet M; White PW
    Biochemistry; 2009 Feb; 48(4):744-53. PubMed ID: 19119853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanistic role of an NS4A peptide cofactor with the truncated NS3 protease of hepatitis C virus: elucidation of the NS4A stimulatory effect via kinetic analysis and inhibitor mapping.
    Landro JA; Raybuck SA; Luong YP; O'Malley ET; Harbeson SL; Morgenstern KA; Rao G; Livingston DJ
    Biochemistry; 1997 Aug; 36(31):9340-8. PubMed ID: 9235976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-genotypic interaction between hepatitis C virus NS3 protease domains and NS4A cofactors.
    Wright-Minogue J; Yao N; Zhang R; Butkiewicz NJ; Baroudy BM; Lau JY; Hong Z
    J Hepatol; 2000 Mar; 32(3):497-504. PubMed ID: 10735621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of hepatitis C virus NS3 proteinase activity by association with NS4A-specific synthetic peptides: identification of sequence and critical residues of NS4A for the cofactor activity.
    Butkiewicz NJ; Wendel M; Zhang R; Jubin R; Pichardo J; Smith EB; Hart AM; Ingram R; Durkin J; Mui PW; Murray MG; Ramanathan L; Dasmahapatra B
    Virology; 1996 Nov; 225(2):328-38. PubMed ID: 8918919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A central hydrophobic domain of the hepatitis C virus NS4A protein is necessary and sufficient for the activation of the NS3 protease.
    Tomei L; Failla C; Vitale RL; Bianchi E; De Francesco R
    J Gen Virol; 1996 May; 77 ( Pt 5)():1065-70. PubMed ID: 8609472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C NS3 protease: restoration of NS4A cofactor activity by N-biotinylation of mutated NS4A using synthetic peptides.
    Butkiewicz NJ; Yao N; Wright-Minogue J; Zhang R; Ramanathan L; Lau JY; Hong Z; Dasmahapatra B
    Biochem Biophys Res Commun; 2000 Jan; 267(1):278-82. PubMed ID: 10623610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C virus NS3 serine proteinase: trans-cleavage requirements and processing kinetics.
    Lin C; Prágai BM; Grakoui A; Xu J; Rice CM
    J Virol; 1994 Dec; 68(12):8147-57. PubMed ID: 7966606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uncoupling of Protease
    Zheng F; Lu G; Li L; Gong P; Pan Z
    J Virol; 2017 Nov; 91(21):. PubMed ID: 28835495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The GB virus C (GBV-C) NS3 serine protease inhibits HIV-1 replication in a CD4+ T lymphocyte cell line without decreasing HIV receptor expression.
    George SL; Varmaz D; Tavis JE; Chowdhury A
    PLoS One; 2012; 7(1):e30653. PubMed ID: 22292009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetic and structural analyses of hepatitis C virus polyprotein processing.
    Bartenschlager R; Ahlborn-Laake L; Mous J; Jacobsen H
    J Virol; 1994 Aug; 68(8):5045-55. PubMed ID: 8035505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GB virus B disrupts RIG-I signaling by NS3/4A-mediated cleavage of the adaptor protein MAVS.
    Chen Z; Benureau Y; Rijnbrand R; Yi J; Wang T; Warter L; Lanford RE; Weinman SA; Lemon SM; Martin A; Li K
    J Virol; 2007 Jan; 81(2):964-76. PubMed ID: 17093192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.